ES2060362T3 - Metodo para aumentar la fertilidad en los machos. - Google Patents

Metodo para aumentar la fertilidad en los machos.

Info

Publication number
ES2060362T3
ES2060362T3 ES91902935T ES91902935T ES2060362T3 ES 2060362 T3 ES2060362 T3 ES 2060362T3 ES 91902935 T ES91902935 T ES 91902935T ES 91902935 T ES91902935 T ES 91902935T ES 2060362 T3 ES2060362 T3 ES 2060362T3
Authority
ES
Spain
Prior art keywords
males
increase fertility
fertility
administration
mammal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91902935T
Other languages
English (en)
Inventor
Kenneth M Attie
Jennie P Mather
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Application granted granted Critical
Publication of ES2060362T3 publication Critical patent/ES2060362T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Paper (AREA)
  • Control Of Steam Boilers And Waste-Gas Boilers (AREA)
  • Sorption Type Refrigeration Machines (AREA)
  • Steroid Compounds (AREA)
  • Fats And Perfumes (AREA)
  • Production Of Liquid Hydrocarbon Mixture For Refining Petroleum (AREA)
  • Display Devices Of Pinball Game Machines (AREA)

Abstract

SE FACILITA UN METODO PARA INCREMENTAR LA FERTILIDAD DE UN MAMIFERO MACHO QUE MUESTRA INSUFICIENCIA DEL EPITELIO GERMINAL QUE COMPRENDE LA ADMINISTRACION AL MAMIFERO DE UNA CANTIDAD EFICAZ DE ACTIVINA. PREFERIBLEMENTE, LA ADMINISTRACION SE EFECTUA EN EL TESTIS DEL MAMIFERO.
ES91902935T 1990-01-08 1991-01-04 Metodo para aumentar la fertilidad en los machos. Expired - Lifetime ES2060362T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/461,714 US5166190A (en) 1990-01-08 1990-01-08 Method for increasing fertility in males

Publications (1)

Publication Number Publication Date
ES2060362T3 true ES2060362T3 (es) 1994-11-16

Family

ID=23833655

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91902935T Expired - Lifetime ES2060362T3 (es) 1990-01-08 1991-01-04 Metodo para aumentar la fertilidad en los machos.

Country Status (10)

Country Link
US (1) US5166190A (es)
EP (1) EP0510073B1 (es)
JP (1) JPH05503701A (es)
AT (1) ATE92330T1 (es)
AU (1) AU634862B2 (es)
CA (1) CA2069442A1 (es)
DE (1) DE69100231T2 (es)
DK (1) DK0510073T3 (es)
ES (1) ES2060362T3 (es)
WO (1) WO1991010444A1 (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6150328A (en) 1986-07-01 2000-11-21 Genetics Institute, Inc. BMP products
SE8901127D0 (sv) * 1989-03-31 1989-03-31 Aa H L Pousette Reagenssats och dess anvaending foer att bilda (spap-anti-spap) -immunkomplex samt diagnostiskt foerfarand vid vilket spap detekteras
US5102868A (en) * 1990-01-08 1992-04-07 Genentech, Inc. Method for inhibiting follicular maturation
US5304603A (en) * 1991-06-18 1994-04-19 The Population Council Leydig cell stimulator
WO1993009229A1 (en) 1991-11-04 1993-05-13 Genetics Institute, Inc. Recombinant bone morphogenetic protein heterodimers, compositions and methods of use
US5563059A (en) * 1993-02-23 1996-10-08 Genentech, Inc. Use of human inhibin and human activin to increase the number of mature primate oocytes
WO1994026892A1 (en) * 1993-05-12 1994-11-24 Genetics Institute, Inc. Bmp-11 compositions
US6291206B1 (en) 1993-09-17 2001-09-18 Genetics Institute, Inc. BMP receptor proteins
AU689184B2 (en) 1993-12-07 1998-03-26 Genetics Institute, Llc BMP-12, BMP-13 and tendon-inducing compositions thereof
US5658876A (en) * 1994-04-28 1997-08-19 The General Hospital Corporation Activin antagonists as novel contraceptives
US5545616A (en) * 1994-09-22 1996-08-13 Genentech, Inc. Method for predicting and/or preventing preterm labor
CA2137219C (en) * 1994-12-02 1997-10-21 Salva Gideon Extract for improving male sperm count and use as anti-microbial or anti-inflammatory agent
JP2001517927A (ja) * 1996-02-28 2001-10-09 バンダービルト ユニバーシティ 胚幹細胞を作製する組成物および方法
DE19641378C1 (de) * 1996-09-27 1998-04-02 Ihf Inst Fuer Hormon Und Fortp Diagnosehilfe sowie Verfahren zum Nachweis der Trächtigkeit von Wiederkäuern
AUPO439396A0 (en) * 1996-12-24 1997-01-23 Walter And Eliza Hall Institute Of Medical Research, The A method of treatment and prophylaxis
AUPO550897A0 (en) * 1997-03-06 1997-03-27 Luminis Pty Limited Treatment and diagnosis of an infertility condition
AU722150B2 (en) * 1997-03-06 2000-07-20 University Of Adelaide, The Treatment and diagnosis of infertility using TGFbeta or activin
JP2002521025A (ja) * 1998-07-24 2002-07-16 ザ カーネギー インスチチューション オブ ワシントン 増殖因子のＴＧＦ−βファミリーのメンバーを使用する、生殖系列幹細胞の維持および増殖のための方法。
US6727224B1 (en) 1999-02-01 2004-04-27 Genetics Institute, Llc. Methods and compositions for healing and repair of articular cartilage
DK1223990T3 (da) 1999-10-15 2004-11-29 Inst Genetics Llc Formuleringer af hyaluronsyre til tilförsel af osteogene proteiner
EP1303270B1 (en) * 2000-07-10 2006-03-29 Hormos Medical Ltd. Method for treating cryptorchidism
TW200526779A (en) * 2001-02-08 2005-08-16 Wyeth Corp Modified and stabilized GDF propeptides and uses thereof
AU2002339299A1 (en) * 2001-05-18 2002-12-03 Cornell Research Foundation, Inc. In vitro production of haploid germ cells
US7226587B2 (en) 2001-06-01 2007-06-05 Wyeth Compositions and methods for systemic administration of sequences encoding bone morphogenetic proteins
TWI267378B (en) 2001-06-08 2006-12-01 Wyeth Corp Calcium phosphate delivery vehicles for osteoinductive proteins
RU2200012C1 (ru) * 2002-03-22 2003-03-10 Артюхин Александр Александрович Способ лечения больных с нарушением мужской половой функции методом трансплантации
RU2200010C1 (ru) * 2002-03-22 2003-03-10 Артюхин Александр Александрович Способ лечения больных с нарушением мужской половой функции методом трансплантации
US7345073B2 (en) 2003-02-07 2008-03-18 Hormos Medical Ltd. Method for treating cryptorchidism
JP5392981B2 (ja) 2003-09-12 2014-01-22 ワイス・エルエルシー 骨形成蛋白の送達のための注入可能なリン酸カルシウム固体ロッドおよびペースト
DE102005033972A1 (de) 2005-07-20 2007-01-25 Dürr Systems GmbH Beschichtungsverfahren und zugehörige Beschichtungseinrichtung
WO2013131979A2 (en) 2012-03-06 2013-09-12 Kernan Colm A communication system for text messages

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4734398A (en) * 1983-03-15 1988-03-29 University Of Southern California Follicular regulating protein
US4764502A (en) * 1983-03-15 1988-08-16 University Of Southern California Intragonadal regulatory protein
CA1268417A (en) * 1984-10-11 1990-05-01 Gere S. Dizerega Intragonadal regulatory protein
US4798885A (en) * 1986-02-07 1989-01-17 Genentech, Inc. Compositions of hormonally active human and porcine inhibin containing an α chain and 62 chain
US4864019A (en) * 1985-11-08 1989-09-05 The Salk Institute For Biological Studies Antibodies to inhibin and conjugates produced therefrom
US4997815A (en) * 1988-11-01 1991-03-05 Children's Hospital Medical Center Of Northern California Method for augmenting fetal hemoglobin by treatment with activin and/or inhibin

Also Published As

Publication number Publication date
WO1991010444A1 (en) 1991-07-25
CA2069442A1 (en) 1991-07-09
EP0510073A1 (en) 1992-10-28
AU634862B2 (en) 1993-03-04
JPH05503701A (ja) 1993-06-17
EP0510073B1 (en) 1993-08-04
DE69100231T2 (de) 1994-01-13
DE69100231D1 (de) 1993-09-09
AU7150491A (en) 1991-08-05
ATE92330T1 (de) 1993-08-15
DK0510073T3 (da) 1993-11-29
US5166190A (en) 1992-11-24

Similar Documents

Publication Publication Date Title
ES2060362T3 (es) Metodo para aumentar la fertilidad en los machos.
ES2111006T3 (es) Fibra optica con aditivo fluorescente.
JPS5360651A (en) Semiconductor laser with optical fibers
ES2071227T3 (es) Composicion para gotas para los ojos.
ES2071607T3 (es) Cubierta de empalme de fibra optica.
DE3279539D1 (en) Multimode fiber optic rotation sensor
AU3345284A (en) Fiber optic amplifier
ES2116279T3 (es) Composicion de caucho.
ES2041754T3 (es) Modulo laser y metodo para el acoplamiento de una fibra optica.
ES2079559T3 (es) Composicion detergente.
ES2053458T3 (es) Utilizacion de prostaglandinas a, b y c y derivados de las mismas, para el tratamiento de la hipertension ocular y glaucoma.
CO4230097A1 (es) Piridopirimidinas sustituidas como antihipertensivos
ES2046889T3 (es) Metodo para inhibicion de la maduracion folicular.
ZA908151B (en) Light fittings
ES2039461T3 (es) Alimentacion de fibras opticas.
ES2042762T3 (es) Servofreno.
ES2089910T3 (es) Acabado antiestatico para fibras teñibles de poli(isoftalamida de m-fenileno) que contienen un agente tensoactivo.
JPS5576316A (en) Connection structure of optical fiber
ES2030846T3 (es) Composicion hibrida de combustible diesel.
ES2057792T3 (es) Procedimiento para la preparacion de cetonas terpenicas.
JPS5524460A (en) Semiconductor laser system
GB871382A (en) Improvements in or relating to methods of manufacturing waveguide structures
JPS5419762A (en) Optical coupling method
JPS529452A (en) Diffusion plate
ES2081470T3 (es) Composiciones y metodos para aliviar los sintomas menopausicos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 510073

Country of ref document: ES